[go: up one dir, main page]

WO2025049438A3 - Molecule screening system - Google Patents

Molecule screening system Download PDF

Info

Publication number
WO2025049438A3
WO2025049438A3 PCT/US2024/043980 US2024043980W WO2025049438A3 WO 2025049438 A3 WO2025049438 A3 WO 2025049438A3 US 2024043980 W US2024043980 W US 2024043980W WO 2025049438 A3 WO2025049438 A3 WO 2025049438A3
Authority
WO
WIPO (PCT)
Prior art keywords
screening system
fixed
molecule screening
length
representation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/043980
Other languages
French (fr)
Other versions
WO2025049438A2 (en
Inventor
Edward Boyden
Chi Zhang
Tay SHIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of WO2025049438A2 publication Critical patent/WO2025049438A2/en
Publication of WO2025049438A3 publication Critical patent/WO2025049438A3/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30Prediction of properties of chemical compounds, compositions or mixtures
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • G06N3/04Architecture, e.g. interconnection topology
    • G06N3/044Recurrent networks, e.g. Hopfield networks

Landscapes

  • Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Computing Systems (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Computational Linguistics (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Artificial Intelligence (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mathematical Physics (AREA)
  • Software Systems (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)

Abstract

A sequence-to-fixed-length transformation is used to process a sequence representation of a molecule structure to yield a fixed-length representation. A transformation of the fixed-length representation yields a prediction of one or more properties of the molecular structure. For example, the molecular structure is a candidate drug and the process described above is part of a screening procedure.
PCT/US2024/043980 2023-08-30 2024-08-27 Molecule screening system Pending WO2025049438A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363535458P 2023-08-30 2023-08-30
US63/535,458 2023-08-30

Publications (2)

Publication Number Publication Date
WO2025049438A2 WO2025049438A2 (en) 2025-03-06
WO2025049438A3 true WO2025049438A3 (en) 2025-04-24

Family

ID=94820271

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/043980 Pending WO2025049438A2 (en) 2023-08-30 2024-08-27 Molecule screening system

Country Status (1)

Country Link
WO (1) WO2025049438A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100312538A1 (en) * 2007-11-12 2010-12-09 In-Silico Sciences, Inc. Apparatus for in silico screening, and method of in siloco screening
US20190304568A1 (en) * 2018-03-30 2019-10-03 Board Of Trustees Of Michigan State University System and methods for machine learning for drug design and discovery
US20210081804A1 (en) * 2017-05-30 2021-03-18 GTN Ltd. Tensor network machine learning system
US20220051759A1 (en) * 2018-09-13 2022-02-17 Cyclica Inc. Method and system for predicting properties of chemical structures
US20220415433A1 (en) * 2020-07-21 2022-12-29 Tencent Technology (Shenzhen) Company Limited Drug screening method and apparatus, and electronic device
US20230190736A1 (en) * 2020-04-10 2023-06-22 The Regents Of The University Of California Small molecule therapeutics for the treatment of viral infections

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100312538A1 (en) * 2007-11-12 2010-12-09 In-Silico Sciences, Inc. Apparatus for in silico screening, and method of in siloco screening
US20210081804A1 (en) * 2017-05-30 2021-03-18 GTN Ltd. Tensor network machine learning system
US20190304568A1 (en) * 2018-03-30 2019-10-03 Board Of Trustees Of Michigan State University System and methods for machine learning for drug design and discovery
US20220051759A1 (en) * 2018-09-13 2022-02-17 Cyclica Inc. Method and system for predicting properties of chemical structures
US20230190736A1 (en) * 2020-04-10 2023-06-22 The Regents Of The University Of California Small molecule therapeutics for the treatment of viral infections
US20220415433A1 (en) * 2020-07-21 2022-12-29 Tencent Technology (Shenzhen) Company Limited Drug screening method and apparatus, and electronic device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHENG SHUANGJIA, YAN XIN, YANG YUEDONG, XU JUN: "Identifying Structure–Property Relationships through SMILES Syntax Analysis with Self-Attention Mechanism", JOURNAL OF CHEMICAL INFORMATION AND MODELING, AMERICAN CHEMICAL SOCIETY , WASHINGTON DC, US, vol. 59, no. 2, 25 February 2019 (2019-02-25), US , pages 914 - 923, XP093307928, ISSN: 1549-9596, DOI: 10.1021/acs.jcim.8b00803 *

Also Published As

Publication number Publication date
WO2025049438A2 (en) 2025-03-06

Similar Documents

Publication Publication Date Title
Wong et al. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics
Hu et al. Identification and proposed relative and absolute configurations of niphimycins C–E from the marine-derived Streptomyces sp. IMB7-145 by genomic analysis
ES8202589A1 (en) Method of synthesizing within a bacterial host a selected mature protein or polypeptide.
Cao et al. Targeted discovery of polycyclic tetramate macrolactams from an environmental Streptomyces strain
ATE274585T1 (en) DNA CHAIN FOR SYNTHESIS OF XANTHOPHYLL AND PROCESS FOR PRODUCING XANTHOPHYLL
Prescher et al. Construction of a 3D-shaped, natural product like fragment library by fragmentation and diversification of natural products
AU2019262112A8 (en) Engineered microorganism for the production of cannabinoid biosynthetic pathway products
ATE168416T1 (en) CELL-FREE SYNTHESIS AND ISOLATION OF GENES AND POLYPEPTIDES
Phan et al. Bacterial cyclophane-containing RiPPs from radical SAM enzymes
Caruso et al. Radical SAM enzyme QmpB installs two 9-membered ring sactionine macrocycles during biogenesis of a ribosomal peptide natural product
Ding et al. Cypemycin Decarboxylase CypD Is Not Responsible for Aminovinyl–Cysteine (AviCys) Ring Formation
WO2021242793A3 (en) Nucleic acid artificial mini-proteome libraries
WO2025049438A3 (en) Molecule screening system
Luber et al. A Single Route to Mammalian N‐Glycans Substituted with Core Fucose and Bisecting GlcNAc
Han et al. Substrate specificity and reaction directionality of a three-residue cyclophane forming enzyme PauB
Yang et al. MGCEP 1.0: A genetic-engineered marine-derived chassis cell for a scaled heterologous expression platform of microbial bioactive metabolites
DiBello et al. Structure elucidation of secondary metabolites: Current frontiers and lingering pitfalls
Vollmann et al. Emerging concepts in the semisynthetic and mutasynthetic production of natural products
Chen et al. De novo design to synthesize lanthipeptides involving cascade cysteine reactions: SapB synthesis as an example
AR125887A1 (en) HUMAN PD-1 AGONIST ANTIBODY AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANTIBODY FOR TREATING OR PREVENTING INFLAMMATORY DISEASES
Wagner et al. Engineering bromodomains with a photoactive amino acid by engaging ‘Privileged’tRNA synthetases
Seebeck et al. Artificial lantipeptides from in vitro translations
de Jesus et al. Revisiting the Reaction of Sulfur Ylides with Acetylenic Esters: Synthesis of Trisubstituted 1, 3‐Dienes, α‐Carbonyl Vinyl Sulfoxides and α‐Carbonyl Vinyl Sulfoxonium Ylides
Fang et al. Genomic scanning enabling discovery of a new antibacterial bicyclic carbamate-containing alkaloid
Kawakami et al. Genetically encoded libraries of nonstandard peptides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24860862

Country of ref document: EP

Kind code of ref document: A2